Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amerise BiosciencesBOM:531681 35 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates BOM:531681 with a GF Score™ of 35/100. Among 75 Diversified Financial Services companies, Amerise Biosciences ranks worse than 1333332% on this metric.
The historical rank and industry rank for Amerise Biosciences's Days Payable or its related term are showing as below:
During the past 13 years, Amerise Biosciences's highest Days Payable was 113215.05. The lowest was 137.29. And the median was 4387.30.
BOM:531681's Days Payable is not ranked *
in the Diversified Financial Services industry.
Industry Median: 69.86 * Ranked among companies with meaningful Days Payable only.
Amerise Biosciences's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
stayed the same
The historical data trend for Amerise Biosciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:531681 vs XXI, CCXI, DMII: Days Payable Comparison
For the Shell Companies subindustry, Amerise Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amerise Biosciences Days Payable vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Amerise Biosciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Amerise Biosciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Amerise Biosciences's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amerise Biosciences (BOM:531681) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amerise Biosciences and its competitors. Over the past decade, Amerise Biosciences' Days Payable has ranged from 137.29 to 113,215.05. According to the industry distribution chart, Amerise Biosciences ranks #999999 out of 75 companies in the Diversified Financial Services industry.
Is Amerise Biosciences' Days Payable too high?
Amerise Biosciences' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 137.29 to a high of 113,215.05. Based on the distribution chart, Amerise Biosciences ranks #999999 out of 75 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Amerise Biosciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Amerise Biosciences' Days Payable compare to XXI and CCXI?
According to the Diversified Financial Services industry distribution chart, Amerise Biosciences ranks #999999 out of 75 companies for Days Payable. This places Amerise Biosciences in the lower half of its industry. The industry median Days Payable is 69.86. Historically, Amerise Biosciences' own Days Payable has ranged from 137.29 to 113,215.05 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Diversified Financial Services company?
The median Days Payable among Diversified Financial Services companies is 69.86, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amerise Biosciences and its competitors. For the Diversified Financial Services industry, the median Days Payable is 69.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amerise Biosciences's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amerise Biosciences stock overvalued right now?
Amerise Biosciences (BOM:531681) has a current Days Payable of 0.00. The current Days Payable is 0.00. Amerise Biosciences' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Amerise Biosciences (BOM:531681), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531681 has been successfully added to your 
